| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/18/1997 | WO1997033901A1 Smooth muscle cell lim protein |
| 09/18/1997 | WO1997033900A1 E2a-binding protein |
| 09/18/1997 | WO1997033899A1 Apoptosis inducing molecule i |
| 09/18/1997 | WO1997033898A1 Human 4-1bb receptor splicing variant |
| 09/18/1997 | WO1997033623A1 OLIGONUCLEOTIDES TARGETED TO ANGIOTENSINOGEN mRNA |
| 09/18/1997 | WO1997033616A1 Methods for treatment of allergic diseases with ige |
| 09/18/1997 | WO1997033613A1 Parasite-derived anti-inflammatory immunomodulatory protein |
| 09/18/1997 | WO1997033609A1 VASOACTIVE EFFECTS AND FREE RADICAL GENERATION BY β-AMYLOID PEPTIDES |
| 09/18/1997 | WO1997033608A2 Antagonism of endothelin actions |
| 09/18/1997 | WO1997033607A1 Orally-administered interferon-tau compositions and methods |
| 09/18/1997 | WO1997033606A1 PROGRAMMED CELL DEATH AND INTERLEUKIN-1$g(b) |
| 09/18/1997 | WO1997033604A1 Treatment of hiv-infection by interfering with host cell cyclophilin receptor activity |
| 09/18/1997 | WO1997033603A1 Novel peptides which inhibit complement activation |
| 09/18/1997 | WO1997033602A1 Peptides with increased binding affinity for hla molecules |
| 09/18/1997 | WO1997033601A1 Inhibition of intracellular signal transduction by 14-3-3-binding peptides |
| 09/18/1997 | WO1997033595A1 Burn shock resuscitation using modified hemoglobin |
| 09/18/1997 | WO1997033580A1 Maintaining kidney function during surgery or trauma |
| 09/18/1997 | WO1997033551A2 Compositions and methods for the diagnosis, prevention, and treatment of neoplastic cell growth and proliferation |
| 09/18/1997 | WO1997033550A2 Methods and compositions for diagnosis and treatment of pathological conditions related to abnormal dopamine receptor expression |
| 09/18/1997 | WO1997033531A1 Oral peptide pharmaceutical products |
| 09/18/1997 | WO1997025351A3 INHIBITORS OF MAdCAM-1-MEDIATED INTERACTIONS AND METHODS OF USE THEREFOR |
| 09/18/1997 | WO1997025343A3 Antithrombotic agents and methods of use |
| 09/18/1997 | WO1997022695A3 Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer |
| 09/18/1997 | WO1997020569A3 Bioartificial devices and cellular matrices therefor |
| 09/18/1997 | WO1997007815A3 Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis |
| 09/18/1997 | CA2407668A1 Human bikunin |
| 09/18/1997 | CA2391818A1 Antagonism of endothelin actions |
| 09/18/1997 | CA2249182A1 Death domain containing receptors |
| 09/18/1997 | CA2249007A1 Parasite-derived anti-inflammatory immunomodulatory protein |
| 09/18/1997 | CA2248998A1 Inhibiting protein interactions |
| 09/18/1997 | CA2248932A1 Oligonucleotides targeted to angiotensinogen mrna |
| 09/18/1997 | CA2248927A1 Smooth muscle cell lim protein |
| 09/18/1997 | CA2248782A1 Lytic peptides |
| 09/18/1997 | CA2248707A1 Clostridium perfringens vaccines |
| 09/18/1997 | CA2248684A1 Immunity to trypanosomatids species |
| 09/18/1997 | CA2248657A1 Peptides with increased binding affinity for hla molecules |
| 09/18/1997 | CA2248613A1 Vasoactive effects and free radical generation by .beta.-amyloid peptides |
| 09/18/1997 | CA2248551A1 Programmed cell death and interleukin-1.beta. |
| 09/18/1997 | CA2248549A1 Extracellular matrix signalling molecules |
| 09/18/1997 | CA2248538A1 Targeted delivery of genes encoding interferon |
| 09/18/1997 | CA2248537A1 Immunomodulatory peptides of vespid antigen 5 |
| 09/18/1997 | CA2248355A1 Human membrane antigen tm4 superfamily protein and dna encoding this protein |
| 09/18/1997 | CA2248192A1 Treatment of hiv-infection by interfering with host cell cyclophilin receptor activity |
| 09/18/1997 | CA2247888A1 Human bikunin |
| 09/18/1997 | CA2247804A1 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 09/18/1997 | CA2246768A1 Uses of gdnf and gdnf receptor |
| 09/18/1997 | CA2246427A1 Methods for treatment of allergic diseases with ige |
| 09/18/1997 | CA2225913A1 Persephin and related growth factors |
| 09/17/1997 | EP0795608A1 Antithrombotic agent and anti-von willebrand factor monoclonal antibodies |
| 09/17/1997 | EP0795605A1 Denatured low-density lipoprotein receptor |
| 09/17/1997 | EP0795562A1 Novel oxyntomodulin |
| 09/17/1997 | EP0795333A2 TGF-beta regulating substance for treatment of myopia or hyperopia |
| 09/17/1997 | EP0795332A2 Medical use of gamma-interferon in interstitial lung diseases |
| 09/17/1997 | EP0795327A1 Use of Amlodipine for the treatment and prophylaxis of congestive cardiac failure of non-ischaemic origin |
| 09/17/1997 | EP0795017A1 Hippocampus-associated proteins, dna sequences coding therefor and uses thereof |
| 09/17/1997 | EP0795015A1 Plasmids suitable for il-2 expression |
| 09/17/1997 | EP0795014A1 Purified genes encoding mammalian cell surface antigens; proteins and antibodies |
| 09/17/1997 | EP0795013A1 Receptor for cell-binding domain of thrombospondins |
| 09/17/1997 | EP0795011A1 Method and compositions for reducing cholesterol absorption |
| 09/17/1997 | EP0795007A1 Bioengineered human blood cells |
| 09/17/1997 | EP0795006A1 HUMAN MutT2 |
| 09/17/1997 | EP0794966A1 Humanized antibodies to cd38 |
| 09/17/1997 | EP0794965A1 Factor vii fragment 82-128 and its use in blood-clotting disorders |
| 09/17/1997 | EP0794963A2 A method of identifying cftr-binding compounds useful for activating chloride conductance in animal cells |
| 09/17/1997 | EP0794961A2 Lhrh antagonist peptides |
| 09/17/1997 | EP0794959A1 Amino acids for making betides and methods of screening and making betide libraries |
| 09/17/1997 | EP0794824A1 Method and device for separating fibrin monomer from blood plasma |
| 09/17/1997 | EP0794797A1 Methods and devices for immunizing a host through administration of naked polynucleotides which encode antigenic peptides |
| 09/17/1997 | EP0794794A1 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
| 09/17/1997 | EP0794792A1 Method of promoting an immune response with a bispecific antibody |
| 09/17/1997 | EP0794791A1 New therapeutical utilization of superoxide dismutases |
| 09/17/1997 | EP0794790A1 Localized delivery of factors enhancing survival of transplanted cells |
| 09/17/1997 | EP0794789A1 Inhibitors of prenyl transferases |
| 09/17/1997 | EP0794785A1 Growth factor expression in human pregnant cervix |
| 09/17/1997 | EP0794782A1 Cobalt schiff base compounds |
| 09/17/1997 | EP0590060B1 Orally administrable therapeutic proteins and method of making |
| 09/17/1997 | EP0537280B1 Preparation and use of transfer factor |
| 09/17/1997 | CN1159831A Vaccines containing borrelia burgdorferi OSPG |
| 09/17/1997 | CN1159830A Immunomodulators |
| 09/17/1997 | CN1159829A 17q-linked breast and ovarian cancer susceptibility gene |
| 09/17/1997 | CN1159828A Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin |
| 09/17/1997 | CN1159827A FLT-4 (fms-like tyrosine-kinase), FLT-15, variants thereof uses as growth factor inhibitors |
| 09/17/1997 | CN1159811A Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof |
| 09/17/1997 | CN1159761A Vaccine compositions |
| 09/17/1997 | CN1159759A Compositions containing tumor rejection antigen precursors or tumor rejection antigens, and an adjuvant and/or growth factor |
| 09/17/1997 | CN1159758A Peptide, a method of obtaining it and a pharmaceutical compound based on it |
| 09/16/1997 | US5668291 Thiosubstituted pyridines, treatment of aids and hiv |
| 09/16/1997 | US5668289 Pyridinone thrombin inhibitors |
| 09/16/1997 | US5668267 Polynucleotides encoding mammaglobin, a mammary-specific breast cancer protein |
| 09/16/1997 | US5668265 Anticoagulants |
| 09/16/1997 | US5668256 Chimeric interleukin 5-receptor/immunoglobulin polypeptides |
| 09/16/1997 | US5668254 Bioactive, oxidation resistance |
| 09/16/1997 | US5668178 Viricide, bactericide, hiv |
| 09/16/1997 | US5668158 Cyclic amino acid derivatives |
| 09/16/1997 | US5668155 Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders |
| 09/16/1997 | US5668128 Aziridine derivatives, their production and use |
| 09/16/1997 | US5668126 Bile acid derivatives, processes for their preparation, and use as pharmaceuticals |
| 09/16/1997 | US5668117 Nervous system disorders using aromatic acid compounds |
| 09/16/1997 | US5668112 Hydrophobic peptide esters and amides |
| 09/16/1997 | US5668111 Sustained-release preparation |